Cited by 267Prostate Cancer Treatment and ResearchCancer, Lipids, and MetabolismSperm and Testicular Function

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer

Open access

Uemura, Motohide, Tamura, Kenji, Chung, Suyoun, Honma, Seijiro, Okuyama, Akihiko, Nakamura, Yusuke, Nakagawa, Hidewaki·2008·Cancer Science

DOI 10.1111/j.1349-7006.2007.00656.xPMC PMC11158902

Open this paper in CoChat — free account Open PDF

Abstract

Prostate cancer often relapses during androgen-depletion therapy, even under conditions in which a drastic reduction of circulating androgens is observed. There is some evidence that androgens remain present in the tissues of hormone-refractory prostate cancers (HRPC), and enzymes involved in the androgen and steroid metabolic pathway are likely to be active in HRPC cells. We previously carried out a genome-wide gene expression profile analysis of clinical HRPC cells by means of cDNA microarrays in combination with microdissection of cancer cells and found dozens of transactivated genes. Among them, we here report the identification of a novel gene, SRD5A2L, encoding a putative 5 alpha-steroid reductase that produces the most potent androgen, 5 alpha-dihydrotestosterone (DHT), from testosterone. Liquid chromatography-tandem mass spectrometry analysis following an in vitro 5 alpha-steroid reductase reaction validated its ability to produce DHT from testosterone, similar to type 1 5 alpha-steroid reductase. Because two types of 5 alpha-steroid reductase were previously reported, we termed this novel 5 alpha-steroid reductase 'type 3 5 alpha-steroid reductase' (SRD5A3). Reverse transcription-polymerase chain reaction and northern blot analyses confirmed its overexpression in HRPC cells, and indicated no or little expression in normal adult organs. Knockdown of SRD5A3 expression by small interfering RNA in prostate cancer cells resulted in a significant decrease in DHT production and a drastic reduction in cell viability. These findings indicate that a novel type 3 5 alpha-steroid reductase, SRD5A3, is associated with DHT production and maintenance of androgen-androgen receptor-pathway activation in HRPC cells, and that this enzymatic activity should be a promising molecular target for prostate cancer therapy.

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2007.00656.x

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
Petrylak, D. P., Tangen, C. M., Hussain, M., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D. L., Moinpour, C. M., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,588
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
The Influence of Finasteride on the Development of Prostate Cancer
Sathianathen, N. J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,082
Prostate cancer epidemiology
Grönberg, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12713-4 · Cited by 1,218
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
McConnell, J. D., Bruskewitz, R., Walsh, P., Andriole, G., Lieber, M., Holtgrewe, H. L., Albertsen, P., Roehrborn, C. G., Nickel, J. C., Wang, D. Z., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380901 · Cited by 1,120
Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., & Russell, D. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116665 · Cited by 727
The Androgen Axis in Recurrent Prostate Cancer
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675

Show all 29 references

Sorted by citations

Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
Steroidogenesis in the skin: Implications for local immune functions
Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.006 · Cited by 369
The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
Azzouni, F. S., Godoy, A., Li, Y., & Mohler, J. L. (2011) · Advances in Urology · doi:10.1155/2012/530121 · Cited by 335
Androgens and estrogens in benign prostatic hyperplasia: Past, present and future
Nicholson, T. M., & Ricke, W. A. (2011) · Differentiation · doi:10.1016/j.diff.2011.04.006 · Cited by 342
SRD5A3 Is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder
Cantagrel, V., Lefeber, D. J., Ng, B. G., Guan, Z., Silhavy, J. L., Bielas, S. L., Lehle, L., Hombauer, H., Adamowicz, M., Swiezewska, E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.001 · Cited by 309
Anticancer steroids: linking natural and semi-synthetic compounds
Salvador, J. A. R., Carvalho, J. F. S., Neves, M. A. C., Silvestre, S., Leitão, A. J., Silva, M. M., & Melo, M. L. S. E. (2012) · Natural Product Reports · doi:10.1039/c2np20082a · Cited by 283
The gut microbiota is a major regulator of androgen metabolism in intestinal contents
Colldén, H., Landin, A., Wallenius, V., Elebring, E., Fändriks, L., Nilsson, M. E., Ryberg, H., Poutanen, M., Sjögren, K., Vandenput, L., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2019 · Cited by 257
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C., & Salameh, W. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1067 · Cited by 260
An overview on 5α-reductase inhibitors
Aggarwal, S., Thareja, S., Verma, A., Bhardwaj, T. R., & Kumar, M. (2009) · Steroids · doi:10.1016/j.steroids.2009.10.005 · Cited by 224
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
Androgens and androgen receptor action in skin and hair follicles
Ceruti, J. M., Leirós, G. J., & Balañá, M. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.009 · Cited by 219
The role of androgen and androgen receptor in skin-related disorders
Lai, J.-J., Chang, P., Lai, K.-P., Chen, L., & Chang, C. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1265-x · Cited by 207
Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism
Tamura, K., Makino, A., Hullin‐Matsuda, F., Kobayashi, T., Furihata, M., Chung, S., Ashida, S., Miki, T., Fujioka, T., Shuin, T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0775 · Cited by 206
Self-citation
Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
Ferraldeschi, R., Welti, J. C., Luo, J., Attard, G., & Bono, J. S. D. (2014) · Oncogene · doi:10.1038/onc.2014.115 · Cited by 199
Inhibitors of Testosterone Biosynthetic and Metabolic Activation Enzymes
Ye, L., Su, Z., & Ge, R. (2011) · Molecules · doi:10.3390/molecules16129983 · Cited by 193
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
Crawford, E. D. (2009) · Urology · doi:10.1016/j.urology.2009.03.001 · Cited by 180
Shared and Unique Components of Human Population Structure and Genome-Wide Signals of Positive Selection in South Asia
Metspalu, M., Romero, I. G., Yunusbayev, B., Chaubey, G., Mallick, C. B., Hudjashov, G., Nelis, M., Mägi, R., Metspalu, E., Remm, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.010 · Cited by 170
Mechanisms of crosstalk between endocrine systems: Regulation of sex steroid hormone synthesis and action by thyroid hormones
Duarte‐Guterman, P., Navarro‐Martín, L., & Trudeau, V. L. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.03.015 · Cited by 168
Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy
Cai, C., & Balk, S. P. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0339 · Cited by 163
The Intracrine Sex Steroid Biosynthesis Pathways
Luu-The, V., & Labrie, F. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81010-2 · Cited by 148
Development of the human prostate
Cunha, G. R., Vezina, C. M., Isaacson, D. S., Ricke, W. A., Timms, B. G., Cao, M., Franco, O. E., & Baskin, L. S. (2018) · Differentiation · doi:10.1016/j.diff.2018.08.005 · Cited by 156
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
Jacob, A., Raj, R., Allison, D. B., & Myint, Z. W. (2021) · Cancers · doi:10.3390/cancers13215417 · Cited by 148
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer
Donato, M. D., Cernera, G., Giovannelli, P., Galasso, G., Bilancio, A., Migliaccio, A., & Castoria, G. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.045 · Cited by 132
Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications
Zazzo, E. D., Galasso, G., Giovannelli, P., Donato, M. D., & Castoria, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00002 · Cited by 131
Bisphenol A Exposure during Adulthood Alters Expression of Aromatase and 5α-Reductase Isozymes in Rat Prostate
Castro, B., Sánchez, P., Torres, J. M., Preda, O., del Moral, R. G., & Ortega, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055905 · Cited by 110
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170009 · Cited by 113
Multiple genes recruited from hormone pathways partition maize diterpenoid defences
Ding, Y., Murphy, K. M., Poretsky, E., Mafu, S., Yang, B., Char, S. N., Christensen, S. A., Saldivar, E. V., Wu, M., Wang, Q., et al. (2019) · Nature Plants · doi:10.1038/s41477-019-0509-6 · Cited by 106
Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography–tandem mass spectrometry
McNamara, K. M., Harwood, D. T., Simanainen, U., Walters, K. A., Jimenez, M., & Handelsman, D. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.001 · Cited by 105
Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
Yamana, K., Labrie, F., & Luu-The, V. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.035 · Cited by 107
5α‐reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression
Godoy, A., Kawinski, E., Li, Y., Oka, D., Alexiev, B. A., Azzouni, F. S., Titus, M. A., & Mohler, J. L. (2010) · The Prostate · doi:10.1002/pros.21318 · Cited by 100
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
Gür, S., Kadowitz, P. J., & Hellstrom, W. J. G. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.742885 · Cited by 95
Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
Ferraldeschi, R., Sharifi, N., Auchus, R. J., & Attard, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0931 · Cited by 93
Evolution of steroid-5α-reductases and comparison of their function with 5β-reductase
Langlois, V. S., Zhang, D., Cooke, G. M., & Trudeau, V. L. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.08.004 · Cited by 92
5α-Reductase Type 1 Modulates Insulin Sensitivity in Men
Upreti, R., Hughes, K. A., Livingstone, D. E. W., Gray, C. D., Minns, F. C., Macfarlane, D. P., Marshall, I., Stewart, L. H., Walker, B. R., & Andrew, R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1395 · Cited by 90
5-Alpha reductase deficiency
Okeigwe, I., & Kuohung, W. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000116 · Cited by 82
Skin steroidogenesis in health and disease
Nikolakis, G., Stratakis, C. A., Kanaki, T., Slominski, A., & Zouboulis, C. C. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9390-z · Cited by 76
Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions
Huhtinen, K., Saloniemi-Heinonen, T., Keski-Rahkonen, P., Desai, R., Laajala, D., Ståhle, M., Häkkinen, M. R., Awosanya, M., Suvitie, P., Kujari, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1913 · Cited by 75
Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction
Zwadlo, C., Schmidtmann, E., Szaroszyk, M., Kattih, B., Froese, N., Hinz, H., Schmitto, J. D., Widder, J. D., Bátkai, S., Bähre, H., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012066 · Cited by 75
Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer
Sharifi, N. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1007 · Cited by 78
Updated survey of the steroid-converting enzymes in human adipose tissues
Tchernof, A., Mansour, M. F., Pelletier, M., Boulet, M.-M., Nadeau, M., & Luu-The, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.011 · Cited by 73
Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone
Mizokami, A., Koh, E., Izumi, K., Narimoto, K., Takeda, M., Honma, S., Dai, J., Keller, E. T., & Namiki, M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0070 · Cited by 72
Self-citation
Targeting 5α-reductase for prostate cancer prevention and treatment
Nacusi, L. P., & Tindall, D. J. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.67 · Cited by 69
5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis
Kapp, F., Sommer, A., Kiefer, T., Dölken, G., & Haendler, B. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-1 · Cited by 68
SRD5A3: a surprising role in glycosylation
Stiles, A. R., & Russell, D. W. (2010) · Cell · doi:10.1016/j.cell.2010.07.003 · Cited by 66
The Role of Androgen Signaling in Male Sexual Development at Puberty
Rey, R. A. (2020) · Endocrinology · doi:10.1210/endocr/bqaa215 · Cited by 69
Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone
Mohler, J. L., Titus, M. A., & Wilson, E. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0644 · Cited by 66
The Impact of Point Mutations in the Human Androgen Receptor: Classification of Mutations on the Basis of Transcriptional Activity
Hay, C. W., & McEwan, I. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032514 · Cited by 70
Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity
Kawata, H., Ishikura, N., Watanabe, M., Nishimoto-Kakiuchi, A., Tsunenari, T., & Aoki, Y. (2010) · The Prostate · doi:10.1002/pros.21107 · Cited by 65
Therapy escape mechanisms in the malignant prostate
Santer, F. R., Erb, H. H. H., & McNeill, R. V. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.005 · Cited by 67
Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
Trost, L. W., Saitz, T. R., & Hellstrom, W. J. G. (2013) · Sexual Medicine Reviews · doi:10.1002/smrj.3 · Cited by 65
Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention
Li, J., Ding, Z., Wang, Z., Lu, J.-F., Maity, S. N., Navone, N. M., Logothetis, C. J., Mills, G. B., & Kim, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028840 · Cited by 64
Androgens in women
Azarchi, S., Bienenfeld, A., Sicco, K. L., Marchbein, S., Shapiro, J., & Nagler, A. R. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.08.061 · Cited by 64
Effect of Dutasteride on Intraprostatic Androgen Levels in Men With Benign Prostatic Hyperplasia or Prostate Cancer
Rittmaster, R. S., Hahn, R. G., Ray, P., Shannon, J. B., & Wurzel, R. S. (2008) · Urology · doi:10.1016/j.urology.2008.06.032 · Cited by 63
Inhibitory activities of some traditional Chinese herbs against testosterone 5α-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice
Zhang, B., Zhang, R.-W., Yin, X., Lao, Z., Zhang, Z., Wu, Q., Yu, L., Lai, X., Wan, Y.-H., & Li, G. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.11.012 · Cited by 61
Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
Salvador, J. A. R., Pinto, R. M. A., & Silvestre, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.006 · Cited by 62
Steroidogenic enzyme expression in the human fetal liver and potential role in the endocrinology of pregnancy
O’Shaughnessy, P. J., Monteiro, A., Bhattacharya, S., Fraser, M., & Fowler, P. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas059 · Cited by 58
5α-Reductases in human physiology: an unfolding story
Traish, A. M. (2012) · Endocrine Practice · doi:10.4158/ep12108.ra · Cited by 57
Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer
Attar, R. M., Jure‐Kunkel, M., Balog, A., Cvijic, M. E., Dell-John, J., Rizzo, C. A., Schweizer, L., Spires, T. E., Platero, J. S., Obermeier, M. T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1111 · Cited by 57
Reduced Bone Mass and Muscle Strength in Male 5α-Reductase Type 1 Inactivated Mice
Windahl, S. H., Andersson, N., Börjesson, A. E., Swanson, C., Svensson, J., Movérare-Skrtic, S., Sjögren, K., Shao, R., Lagerquist, M. K., & Ohlsson, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021402 · Cited by 56
5α-Reduced glucocorticoids: a story of natural selection
Nixon, M., Upreti, R., & Andrew, R. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0318 · Cited by 56
Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities
Ruksiriwanich, W., Khantham, C., Muangsanguan, A., Phimolsiripol, Y., Barba, F. J., Sringarm, K., Rachtanapun, P., Jantanasakulwong, K., Jantrawut, P., Chittasupho, C., et al. (2022) · Plants · doi:10.3390/plants11243514 · Cited by 50
Life with too much polyprenol: polyprenol reductase deficiency
Gründahl, J. E. H., Guan, Z., Rust, S., Reunert, J., Müller, B., Chesne, I. D., Zerres, K., Rudnik‐Schöneborn, S., Ortiz‐Brüchle, N., Häusler, M., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.12.017 · Cited by 50
Evolution of Retinoid and Steroid Signaling: Vertebrate Diversification from an Amphioxus Perspective
Albalat, R., Brunet, F., Laudet, V., & Schubert, M. (2011) · Genome Biology and Evolution · doi:10.1093/gbe/evr084 · Cited by 51
Effects on Steroid 5-Alpha Reductase Gene Expression of Thai Rice Bran Extracts and Molecular Dynamics Study on SRD5A2
Khantham, C., Yooin, W., Sringarm, K., Sommano, S. R., Jiranusornkul, S., Carmona, F. D., Nimlamool, W., Jantrawut, P., Rachtanapun, P., & Ruksiriwanich, W. (2021) · Biology · doi:10.3390/biology10040319 · Cited by 48
Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer
Schmidt, L. J., & Tindall, D. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.09.003 · Cited by 47
Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
Robitaille, J., & Langlois, V. S. (2020) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2020.113400 · Cited by 47
Inhibitors of Brassinosteroid Biosynthesis and Signal Transduction
Rozhon, W., Akter, S., Fernandez, A., & Poppenberger, B. (2019) · Molecules · doi:10.3390/molecules24234372 · Cited by 49
The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
Goldenberg, L., So, A., Fleshner, N. E., Rendon, R. A., Drachenberg, D., & ELHILALI, M. M. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.1114 · Cited by 45
Nasal DNA methylation differentiates corticosteroid treatment response in pediatric asthma: A pilot study
Zhang, X., Myers, J. M. B., Yadagiri, V. K., Ulm, A., Chen, X., Weirauch, M. T., Hershey, G. K. K., & Ji, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186150 · Cited by 45
Laser capture microdissection–reduced representation bisulfite sequencing (LCM-RRBS) maps changes in DNA methylation associated with gonadectomy-induced adrenocortical neoplasia in the mouse
Schillebeeckx, M., Schrade, A., Löbs, A., Pihlajoki, M., Wilson, D. B., & Mitra, R. D. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt230 · Cited by 44
Androgen biosynthesis in castration-resistant prostate cancer
Penning, T. M. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0109 · Cited by 48
Biosynthesis of dihydrotestosterone by a pathway that does not require testosterone as an intermediate in the SZ95 sebaceous gland cell line
Samson, M., Labrie, F., Zouboulis, C. C., & Luu-The, V. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.225 · Cited by 42
Reproductive, Physiological, and Molecular Outcomes in Female Mice Deficient in Dhh and Ihh
Liu, C., Rodriguez, K. F., Brown, P. R., & Yao, H. H. (2018) · Endocrinology · doi:10.1210/en.2018-00095 · Cited by 42
A strategic review on the involvement of receptors, transcription factors and hormones in acne pathogenesis
Bharti, S., & Vadlamudi, H. C. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1805626 · Cited by 43
Genetic defects in dolichol metabolism
Buczkowska, A., Świeżewska, E., & Lefeber, D. J. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9760-1 · Cited by 42
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
Xu, P., Wasielewski, L. J., Yang, J. C., Cai, D., Evans, C. P., Murphy, W. J., & Liu, C. (2022) · Biomedicines · doi:10.3390/biomedicines10081778 · Cited by 42
5α‐reductase type 3 enzyme in benign and malignant prostate
Titus, M. A., Li, Y., Kozyreva, O. G., Maher, V., Godoy, A., Smith, G. J., & Mohler, J. L. (2013) · The Prostate · doi:10.1002/pros.22745 · Cited by 40
Variability in the Androgen Response of Prostate Epithelium to 5α-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention
Mostaghel, E. A., Geng, L. N., Holcomb, I. N., Coleman, I. M., Lucas, J. M., True, L. D., & Nelson, P. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2509 · Cited by 40
Testosterone and the Androgen Receptor
Gerald, T., & Raj, G. V. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.004 · Cited by 38
Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
Niu, Y.-N., Wang, K., Fan, D., Jin, S., & Xing, N. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.123664 · Cited by 39
Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Chau, C. H., Price, D. K., Till, C., Goodman, P. J., Chen, X., Leach, R. J., Johnson‐Pais, T. L., Hsing, A. W., Hoque, A. M., Tangen, C. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126672 · Cited by 37
NF‐κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance
Austin, D. C., Strand, D. W., Love, H. L., Franco, O. E., Grabowska, M. M., Miller, N. L., Hameed, O. M., Clark, P. E., Matusik, R. J., Jin, R. J., et al. (2016) · The Prostate · doi:10.1002/pros.23195 · Cited by 37
SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy
Shiota, M., Fujimoto, N., Yokomizo, A., Takeuchi, A., Itsumi, M., Inokuchi, J., Tatsugami, K., Uchiumi, T., & Naito, S. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.122 · Cited by 35
Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
Das, K., Lorena, P. D. N., Ng, L. K., Lim, D. G. S., Shen, L., Siow, W. Y., Teh, M., Reichardt, J. K. V., & Salto‐Tellez, M. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0022 · Cited by 35
Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C19 steroids as the predominant androgens in prostate cancer
du Toit, T., & Swart, A. C. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.026 · Cited by 34
Hamster SRD5A3 lacks steroid 5α-reductase activity in vitro
Chávez, B. A., Ramos, L., Garcı́a-Becerra, R., & Vilchis, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.11.005 · Cited by 34
Prediction of conserved microRNAs from skin and mucosal human papillomaviruses
Gu, W., An, J., Ye, P., Zhao, K., & Antonsson, A. (2011) · Archives of Virology · doi:10.1007/s00705-011-0974-3 · Cited by 34
Promiscuity and diversity in 3-ketosteroid reductases
Penning, T. M., Chen, M., & Jin, Y. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.12.003 · Cited by 36
Molecular mechanism of triple‑negative breast cancer‑associated BRCA1 and the identification of signaling pathways
Qi, F., Qin, W., & Zang, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.9884 · Cited by 32
Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
Giatti, S., Diviccaro, S., Falvo, E., García‐Segura, L. M., & Melcangi, R. C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100836 · Cited by 33
Insulin Resistance and Acne: The Role of Metformin as Alternative Therapy in Men
Andreadi, A., Muscoli, S., Tajmir, R., Meloni, M., Minasi, A., Muscoli, C., Ilari, S., Mollace, V., Della‐Morte, D., Bellia, A., et al. (2022) · Pharmaceuticals · doi:10.3390/ph16010027 · Cited by 31
The androgen receptor
Van-Duyne, G., Blair, I. A., Sprenger, C. C. T., Moiseenkova‐Bell, V. Y., Plymate, S. R., & Penning, T. M. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.01.001 · Cited by 32
Relating sex-bias in human cortical and hippocampal microstructure to sex hormones
Küchenhoff, S., Bayrak, Ş., Zsido, R. G., Saberi, A., Bernhardt, B. C., Weis, S., Schaare, H. L., Sacher, J., Eickhoff, S. B., & Valk, S. L. (2024) · Nature Communications · doi:10.1038/s41467-024-51459-7 · Cited by 31
Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α‐reductase
Vis, A. N., & Schröder, F. H. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08743.x · Cited by 30
Targeting sex steroid biosynthesis for breast and prostate cancer therapy
POUTANEN, M. H., Thulin, M. H., & Härkönen, P. L. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00609-y · Cited by 31
Combination therapy with finasteride and low‐dose dutasteride in the treatment of androgenetic alopecia
Boyapati, A., & Sinclair, R. D. (2012) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2012.00909.x · Cited by 28
Steroidal 5α-Reductase Inhibitors: A Comparative 3D-QSAR Study Review
Thareja, S. (2015) · Chemical Reviews · doi:10.1021/cr5005953 · Cited by 28
Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues
Mansour, M. F., Pelletier, M., & Tchernof, A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.003 · Cited by 27
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial
Price, D. K., Chau, C. H., Till, C., Goodman, P. J., Leach, R. J., Johnson‐Pais, T. L., Hsing, A. W., Hoque, A. M., Parnes, H. L., Schenk, J. M., et al. (2016) · Cancer · doi:10.1002/cncr.30071 · Cited by 27
Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancer
Jardel, P., Debiais, C., Godet, J., Irani, J., & Fromont, G. (2013) · Histopathology · doi:10.1111/his.12129 · Cited by 26

Authors: Uemura, M., Tamura, K., Chung, S., Honma, S., Okuyama, A., Nakamura, Y., & Nakagawa, H.
Affiliations: Institute of Medical Science, The University of Tokyo (JP)
Corresponding author: Nakagawa, Hidewaki
ORCID: Uemura, Motohide
Tamura, Kenji
Nakamura, Yusuke
Nakagawa, Hidewaki
Venue: Cancer Science
Publisher: Wiley
Published: 2007-11-06
Volume: 99
Issue: 1
Pages: 81-86
ISSN: 1347-9032 (ISSN-L)
1349-7006
DOI: 10.1111/j.1349-7006.2007.00656.x
PMC: PMC11158902
OpenAlex: W2029877275
Cited by: 263
References: 29
Citations by year: 2026: 5 · 2025: 12 · 2024: 13 · 2023: 11 · 2022: 12 · 2021: 8 · 2020: 9 · 2019: 13 · 2018: 15 · 2017: 14 · 2016: 16 · 2015: 12 · 2014: 18 · 2013: 21 · 2012: 21
FWCI: 11.52
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Cancer Science (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords: SRD5A3, castration-resistant prostate cancer, dihydrotestosterone, androgen production, androgen receptor signaling, gene overexpression, siRNA knockdown
MeSH terms: Animals, Chlorocebus aethiops, Humans, Male, Neoplasms, Hormone-Dependent, Prostatic Neoplasms, Dihydrotestosterone, Testosterone, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Transfection, COS Cells, RNA, Small Interfering, Cell Line, Tumor, Cell Growth Processes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks